Who owns Kezar Life Sciences Inc?
- CUSIP Number: 49372l100
Tip: Access positions for across all investors
Analyze quarterly positions in Kezar Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kezar Life Sciences stock
Who bought or sold Kezar Life Sciences Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Avidity Partners Management | 5.0M | $3.9M | 0% | Sep 2024 |
|
| Tang Capital Management | 3.6M | $2.8M | 100% | Sep 2024 |
|
| Affinity Asset Advisors | 2.5M | $1.9M | 43% | Sep 2024 |
|
| OrbiMed Advisors | 1.9M | $1.5M | 0% | Sep 2024 |
|
| Acadian Asset Management | 1.6M | $1.2M | -15% | Sep 2024 |
|
| Stonepine Capital Management | 1.5M | $1.2M | 42% | Sep 2024 |
|
| Renaissance Technologies | 1.3M | $1.0M | 67% | Sep 2024 |
|
| Acuitas Investments | 1.2M | $949k | 24% | Sep 2024 |
|
| Ikarian Capital | 1.1M | $827k | 23% | Sep 2024 |
|
| Qiming U.S. Ventures Management | 829k | $638k | 0% | Sep 2024 |
|
| BlackRock | 829k | $641k | 100% | Sep 2024 |
|
| Geode Capital Management | 627k | $485k | 15% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 279k | $215k | 0% | Sep 2024 |
|
| Citadel Advisors | 260k | $201k | -47% | Sep 2024 |
|
| Marquette Asset Management | 178k | $138k | 0% | Sep 2024 |
|
| Northern Trust | 90k | $70k | 100% | Sep 2024 |
|
| Amundi | 82k | $61k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 78k | $60k | -2% | Sep 2024 |
|
| Charles Schwab Investment Management | 63k | $49k | 0% | Sep 2024 |
|
| Jane Street | 60k | $46k | -89% | Sep 2024 |
|
| Ironwood Investment Management | 28k | $22k | 5% | Sep 2024 |
|
| Point72 Asia | 27k | $21k | -74% | Sep 2024 |
|
| RVW Wealth | 24k | $18k | 0% | Sep 2024 |
|
| Valence8 US | 21k | $16k | 100% | Sep 2024 |
|
| Retirement Capital Strategies | 15k | $12k | 100% | Sep 2024 |
|
| Susquehanna International | 13k | $9.7k | -96% | Sep 2024 |
|
| Hrt Financial | 11k | $8.0k | -86% | Sep 2024 |
|
| Ground Swell Capital | 11k | $8.4k | 100% | Sep 2024 |
|
| Engineers Gate Manager | 11k | $8.2k | 100% | Sep 2024 |
|
| Global Retirement Partners | 10k | $7.7k | 0% | Sep 2024 |
|
| Federated Investors | 6.2k | $4.8k | -30% | Sep 2024 |
|
| Advisor Group Holdings | 4.7k | $3.6k | 100% | Sep 2024 |
|
| Simplex Trading | 3.8k | $2.0k | 0% | Sep 2024 |
|
| Bank of America Corporation | 1.7k | $1.3k | -98% | Sep 2024 |
|
| Jpmorgan Chase & Co | 1.7k | $1.3k | -48% | Sep 2024 |
|
| Atlantic Trust | 1.0k | $773.000000 | 0% | Sep 2024 |
|
| Citigroup | 518.00 | $400.983800 | -95% | Sep 2024 |
|
| Barclays | 1.00 | $0 | -100% | Sep 2024 |
|
Who sold out of Kezar Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2024 | 629k | $377k |
| Bnp Paribas Arbitrage, Snc | Jun 2024 | 444k | $266k |
| D. E. Shaw & Co | Jun 2024 | 247k | $148k |
| Y-Intercept | Jun 2024 | 228k | $137k |
| Centiva Capital | Jun 2024 | 148k | $89k |
| T. Rowe Price Associates | Jun 2024 | 84k | $51k |
| Mackenzie Financial | Jun 2024 | 59k | $35k |
| Sunrise Partners Limited Partnership | Jun 2024 | 56k | $34k |
| Schonfeld Strategic Advisors | Jun 2024 | 44k | $27k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 36k | $22k |
| Virtu Financial | Jun 2024 | 36k | $21k |
| Rhumbline Advisers | Jun 2024 | 28k | $17k |
| Jump Financial | Jun 2024 | 23k | $14k |
| XTX Topco | Jun 2024 | 15k | $8.8k |
| JustInvest | Jun 2024 | 13k | $7.6k |
| Occudo Quantitative Strategies | Jun 2024 | 12k | $7.3k |
| Point72 | Jun 2024 | 12k | $7.0k |
| Royal Bank of Canada | Jun 2024 | 3.5k | $2.0k |
| Capital Advisors | Jun 2024 | 719.00 | $0 |
| New York State Common Retirement Fund | Jun 2024 | 605.00 | $0 |
| CWM | Jun 2024 | 79.00 | $0 |